Lung and liver changes during COVID-19 infection in the presence of liver cirrhosis
- Авторлар: Vorobyeva O.V.1, Lastochkin A.V.1,2, Gimaldinova N.E.1, Romanova L.P.1, Yusov A.A.1
-
Мекемелер:
- I.N. Ulyanov Chuvash State University
- Republican Bureau of Forensic Medicine
- Шығарылым: Том 10, № 4 (2020)
- Беттер: 63-65
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/287620
- DOI: https://doi.org/10.18565/epidem.2020.10.4.63-5
- ID: 287620
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Аннотация
Негізгі сөздер
Толық мәтін
Авторлар туралы
Olga Vorobyeva
I.N. Ulyanov Chuvash State University
Email: olavorobeva@mail.ru
Cand. Med. Sci., Associate Professor, Department of General and Clinical Morphology and Forensic Medicine Cheboksary, Russia
Aleksey Lastochkin
I.N. Ulyanov Chuvash State University; Republican Bureau of Forensic Medicine
Email: alllex.08@mail.ru
Highest-Category Pathologist Cheboksary, Russia; Cheboksary, Russia
Natalia Gimaldinova
I.N. Ulyanov Chuvash State University
Email: rufer06@rambler.ru
Cand. Med. Sci., Associate Professor, Department of General and Clinical Morphology and Forensic Medicine Cheboksary, Russia
Lyubov Romanova
I.N. Ulyanov Chuvash State University
Email: samung2008@yandex.ru
Associate Professor, Department of Dermatovenereology with Course of Hygiene Cheboksary, Russia
Aleksandr Yusov
I.N. Ulyanov Chuvash State University
Email: yusov1961@yandexl.ru
Associate Professor, Department of Normal and Pathological Physiology Cheboksary, Russia
Әдебиет тізімі
- Воробьева О.В., Ласточкин А.В. Клиникоморфологический случай COVID-19. Эпидемиол. инфекц. болезни. Актуал. вопр. 2020; 10(2): 90-3. DOI: https://dx.doi.org/10.18565/epidem.2020.2.90-93
- Воробьева О.В., Ласточкин А.В. Патоморфологические изменения в органах при COVID-19. Инфекция и иммунитет 2020; 10(3): 587-90. https://doi.org/10.15789/2220-7619-PCI-1483
- Chai X., Hu L., Zhang Y., Han W., Lu Z., Ke A. et al. Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection. bioRxiv. doi: 10.1101/2020.02.03.931766
- Fan Z., Chen L., Li J., Cheng X., Yang J., Tian C. et al. Clinical features of COVID-19 related liver damage. Clin. Gastroenterol. Hepatol. 2020; 18(7): 1561-6. doi: 10.1016/j. cgh.2020.04.002
- Hamming I., Timens W., Bulthuis M., Lely A.T., Navis G.J., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004; 203: 631-7.
- Li L., Li S., Xu M., Yu P., Zheng S., Dua Z. et al. Risk factors related to hepatic injury in patients with corona virus disease 2019. medRxiv 2020. doi: https://doi.org/10.1101/2020.02.28.20028514.
- Moon A.J. et al. High mortality rate for SARS-CoV2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry. J. Hepatol. (advance online publication), 22 May 2020. https://doi.org/10.1016/johep.2020.05.013
- Sun J., Aghemo A., Forner A., Valenti L. COVID-19 and liver disease. Liver Int. 2020; 40(6): 1278-81. https://doi.org/10.1111/liv.14470
Қосымша файлдар
